In today's pharmaceutical environment, Lifecycle Management is no longer only a regulatory or pharmacovigilance challenge, it is an operational challenge.
As organizations grow internationally, add products, integrate acquisitions, or expand into multiple markets, both Regulatory Affairs and Pharmacovigilance teams face increasing operational complexity. Activities become more interconnected, coordination becomes more difficult, and pressure grows to maintain compliance while controlling workload, timelines, and costs.
This webinar explores how these challenges develop across three common operational scenarios:
- Integration of new product types where internal expertise is limited
- Growing portfolios with constrained internal resources
- Expansion into new markets with limited local knowledge or operational capacity
For each scenario, we will connect operational complexity with its impact on variations, submissions, safety reporting, compliance oversight, and cross-functional coordination.
The session will also highlight:
- Loss of control — Where lifecycle execution typically starts to lose control
- Emerging risks — What risks emerge in terms of compliance, timelines, data consistency, and operational efficiency
- Scalable structure — How organizations can structure Lifecycle Management activities in a more scalable and cost-efficient way
We will conclude with case studies showing how an integrated Lifecycle Management approach helped stabilize operations, reduce complexity, and improve efficiency and cost control across Regulatory and Pharmacovigilance functions.